Extreme hypofractionation with SBRT in localized prostate cancer

MA Gómez-Aparicio, J Valero, B Caballero, R García… - Current …, 2021 - mdpi.com
Prostate cancer is the most commonly diagnosed cancer among men around the world.
Radiotherapy is a standard of care treatment option for men with localized prostate cancer …

Current state of personalized genitourinary cancer radiotherapy in the era of precision medicine

SC Kamran, JA Efstathiou - Frontiers in Oncology, 2021 - frontiersin.org
Radiation therapy plays a crucial role for the management of genitourinary malignancies,
with technological advancements that have led to improvements in outcomes and decrease …

De-escalation of therapy for prostate cancer

T Esen, B Esen, K Yamaoh, U Selek… - American Society of …, 2024 - ascopubs.org
Prostate cancer (PCa) is the second most commonly diagnosed cancer in men with around
1.4 million new cases every year. In patients with localized disease, management options …

SBRT for localized prostate cancer: CyberKnife vs. VMAT-FFF, a dosimetric study

M Serra, F De Martino, F Savino, V d'Alesio… - Life, 2022 - mdpi.com
In recent years, stereotactic body radiation therapy (SBRT) has gained popularity among
clinical methods for the treatment of medium and low risk prostate cancer (PCa), mainly as …

Radiotherapy in oligometastatic prostate cancer—a pattern of care survey among members of the German Society for Radiation Oncology (DEGRO)

P Rogowski, C Trapp, R von Bestenbostel… - Strahlentherapie und …, 2022 - Springer
Purpose Due to improved imaging, oligometastatic prostate cancer (OMPC) is diagnosed
more frequently. Growing evidence shows that patients with a limited number of metastases …

Whole-pelvic irradiation with boost to involved nodes and prostate in node-positive prostate cancer—long-term data from the prospective PLATIN-2 trial

CA Fink, D Wegener, LD Sauer, C Jäkel, D Zips… - Strahlentherapie und …, 2024 - Springer
Purpose Node-positive prostate cancer is a potentially curable disease. Definitive
radiotherapy to the prostate and lymphatic drainage is an effective treatment option but …

Stereotactic body radiotherapy (SIB-VMAT technique) to dominant intraprostatic lesion (DIL) for localized prostate cancer: a dose-escalation trial (DESTROY-4).

F Deodato, M Ferro, P Bonome, D Pezzulla… - Strahlentherapie und …, 2024 - Springer
Abstract Purpose DESTROY—4 (D OSE-E SCALATION STUDY OF ST EREOTACTIC BODY
R ADIATI ON THERAP Y) was a Phase I trial aimed to evaluate the safety and the feasibility …

Hypofractionated Radiotherapy in Localized, Low–Intermediate-Risk Prostate Cancer: Current and Future Prospectives

MC Lo Greco, G Marletta, G Marano, A Fazio… - Medicina, 2023 - mdpi.com
At the time of diagnosis, the vast majority of prostate carcinoma patients have a clinically
localized form of the disease, with most of them presenting with low-or intermediate-risk …

Urethra sparing with target motion mitigation in dose-escalated extreme hypofractionated prostate cancer radiotherapy: 7-year results from a phase II study

C Greco, O Pares, N Pimentel, V Louro, B Nunes… - Frontiers in …, 2022 - frontiersin.org
Purpose To explore whether the rectal distension-mediated technique, harnessing human
physiology to achieve intrafractional prostate motion mitigation, enables urethra sparing by …

Radiation Therapy Summary of the AUA/ASTRO Guideline on Clinically Localized Prostate Cancer

C Deville Jr, SC Kamran, SC Morgan, K Yamoah… - Practical Radiation …, 2024 - Elsevier
Purpose Our purpose was to develop a summary of recommendations regarding the
management of patients with clinically localized prostate cancer based on the American …